ESMO 2012 : Crizotinib, a ready to use drug for NSCLC

ESMO has 24 videos Subscribe Here

Description: Luis Paz-Ares describes results of a new drug for ALK-positive NSCLC patients. These studies were presented during ESMO 2012, the Congress of the European Society for Medical Oncology. Read all the news about the latest in cancer and oncology from the Congress here

The opinion expressed in this interview reflects that of the interviewee and does not necessarily express the official ESMO point of view.
Video produced by the European Society for Medical Oncology (ESMO)
Access all the ESMO scientific video resources:
Shared By : ESMO
Posted on : 10/04/12
Added : 7 years ago
Category : News